ACYTE Biotech supplies proprietary mammalian cell lines and technologies to enhance cell engineering and culture processes to streamline biologics development from discovery to clinic. ACYTE provides biotech companies adaptable, stable and robust cell lines with superior growth performance for expression of monoclonal antibodies, fusion proteins, antibody fragments, recombinant proteins, etc. ACYTE’s suite of SuperCHO® technologies span stable and transient cell lines, antibody vectors and clonal isolation processes.
View Top Employees from ACYTE Biotech| Website | http://www.acyte.com |
| Revenue | $2 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2003 |
| Address | Rupert Myers Bldg Barker St, Sydney, New South Wales 2052, AU |
| Phone | +61 2 9385 3693 |
| Technologies |
JavaScript,
PHP,
Nginx
+3 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular ACYTE Biotech employee's phone or email?
ACYTE Biotech Questions
The ACYTE Biotech annual revenue was $2 million in 2024.
ACYTE Biotech is based in Sydney, New South Wales.
The NAICS codes for ACYTE Biotech are [5417, 541713, 54, 541, 54171].
The SIC codes for ACYTE Biotech are [873, 87].
Related Companies
